WinstonWınston
Back
ECO Animal Health Group logo

ECO Animal Health Group

EAH.L
55
Drug Manufacturers - Specialty & Generic · Healthcare
Price
101.00 GBp
+0.00 (+0.00%)
Market Cap
£67.4M
Exchange
London Stock Exchange
Winston Score
55
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Mar 31, 2026
How the score breaks down
Quality
Mixed
Growth
Good
Cash Flow
Strong
Stability
Exceptional
Valuation
Weak

Winston Score History

The full picture

ECO Animal Health Group is a British company that makes medicines for farm animals. Its main products are antibiotics and other drugs used to keep pigs and poultry healthy on commercial farms. The company sells to livestock farmers, veterinarians, and agricultural distributors, primarily across Asia, Europe, and the Americas.

The company earns money by selling its animal health products directly and through distribution partners in over 60 countries. Its flagship product, Aivlosin, is a proprietary antibiotic licensed for use in pigs and poultry and gives the company a degree of pricing power in its niche. However, ECO Animal Health faces real pressure from growing global restrictions on antibiotic use in livestock, as regulators in many countries are tightening rules to combat antibiotic resistance — this is the single biggest long-term risk to its core business model.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+3.7% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-24.6% YoY

YoY Growth Rate

Earnings declining

Insider Activity

11.4%ownership

Declining

Insider ownership declining — could be dilution or selling

Cash Position

Cash flow positive

£26M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

ECO Animal Health Group is growing revenue at 4% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
47.7%
Healthy — 47.7% gross margin
Profit after running costs
Operating Margin
9.4%
Modest — 9.4% operating margin
Return on the money invested
ROCE
6.3%
Weak — 6.3% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+10.0%
Steady sales growth (+10.0% YoY)
Profit growth
EPS YoY
+29.2%
Earnings growing fast (+29.2% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
353%
Turns 353% of profit into real cash
Spare cash per sale
FCF Margin
8.6%
Modest free cash flow (8.6%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.01
Conservative — low debt load (0.01)
Covers its interest
Interest Cover
13.96x
Comfortably covers interest (14.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
31.3x
no trend
Pricey — P/E 31.3

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial